Contract facts
FederalNo full NAICS 334516 intel page yet. Browse NAICS intelligence
SEQUEL II SEQUENCING KIT 2.0 & SMRT CELL 8M TRAY is a federal award for Usda Ars Pwa Aao Acq/Per Prop held by Pacific Biosciences of California, Inc. Estimated value $105K ($105K obligated). Current period of performance ends Jun 13, 2022. Place of performance: MENLO PARK CA.
SEQUEL II SEQUENCING KIT 2.0 & SMRT CELL 8M TRAY
Recompete timing
PublicCurrent PoP ended Jun 13, 2022 (1571 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Want the durability read on 12905B22F0045? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordPacific Biosciences of California, Inc — $7.8M obligated across 81 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 12905B22F0045?
12905B22F0045 (SEQUEL II sequencing KIT 2.0 SMRT) is a Usda Ars Pwa Aao Acq/Per Prop award with a potential value of $105K, currently held by Pacific Biosciences of California, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 12905B-22-F-0045?
12905B-22-F-0045 is the dashed form of PIID 12905B22F0045 (SEQUEL II sequencing KIT 2.0 SMRT), held by Pacific Biosciences of California, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 12905B22F0045?
Usda Ars Pwa Aao Acq/Per Prop awarded 12905B22F0045 to Pacific Biosciences of California, Inc (potential $105K).
Who is the incumbent on 12905B22F0045?
Pacific Biosciences of California, Inc is the incumbent with $7.8M across 81 related awards in SCOUT’s public footprint. The current period of performance ends Jun 13, 2022.
When does Pacific Biosciences of California, Inc’s 12905B22F0045 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 13, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 12905B22F0045? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.